Study: Even Low-Dose Aspirin Raises GI Bleeding Risk

A new study shows that even use of low-dose aspirin increases the risk of gastrointestinal bleeding, which is increased further with use of cardiovascular disease-preventing therapies, such as clopidogrel and anticoagulants, according to an American Gastroenterological Association news release.

The study, published in Clinical Gastroenterology and Hepatology, also found that bleeding risk decreased in patients on proton pump inhibitors.

The risk of major GI bleeding also increased when aspirin was combined with clopidogrel or anticoagulants or in patients with a history of GI bleeding.

Study: Even Low-Dose Aspirin Raises GI Bleeding Risk

Related Articles on GI Bleeding From Drugs:

Next Up in GI & Endoscopy

Independent GI practices shrinks as reimbursements fall 38% over a decade

Endoscopy at scale: The reprocessing best practices separating high-performing teams

Missouri hospital adds noninvasive liver tumor treatment

Related Articles on GI Bleeding From Drugs:

Navigating Medicare advantage risk in 2027

Next Up in GI & Endoscopy

Independent GI practices shrinks as reimbursements fall 38% over a decade

Endoscopy at scale: The reprocessing best practices separating high-performing teams

Missouri hospital adds noninvasive liver tumor treatment

Join the 40,000+ ASC leaders who start their day with Becker's